Control and prevent optimally the PCVD due to all relevant genotypes while keeping the best Mycoplasma protection
Available in:
Cirbloc® M Hyo is a dual-action swine vaccine developed by Ceva Animal Health to protect pigs against Mycoplasma hyopneumoniae and Porcine Circovirus Type 2 (PCV2).
Designed for a single intramuscular dose from 3 weeks of age. Immunity begins within 2 weeks post-vaccination for PCV2 and 3 weeks post-vaccination for Mycoplasma hyopneumoniae and it lasts up to 26 weeks of age for the 2 pathogens.
Protection against all relevant PCV2 genotypes
Hyogen® backbone based formulation
Nimród Pálmai, Nikoletta-Ágnes Széplaki, Bálint Molnár, Han Smits, Roman Krejci and István Kiss
Non-Compromised-Effi (4.36 MB)Download
Mònica Sagrera, Laura Garza-Moreno, Àlex Cobos, Anna Maria Llorens, Eva Huerta, Mónica Pérez, Diego Pérez, David Espigares, Joaquim Segalés and Marina Sibila
Efficacy-of-a-Novel- (7.63 MB)Download
Peter Trampus, Attila Csagola, Tamas Szalai, Nimrod Palmai, Adam Toth, Nora Terenyi, Zoltan Nagy, Nikoletta-Agnes Szeplaki, Gergely Somogyi, Eniko Rausch, Zoltan Penzes, Roman Krejci
Efficacy-of-a-new-re (365.51 KB)DownloadFrom one country to another, product lines are adapted to local demand and regulatory requirements. For further information, please take a look at the CEVA Santé Animale site for your country. Warning: the information provided on the products depends on national registrations. Access to technical information is restricted to authorised persons.
SWINE 
